TMCnet News
Research and Markets: Chinese Markets for Kidney Cancer Treatment DrugsDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/x5zbxd/chinese_markets) has announced the addition of the "Chinese Markets for Kidney Cancer Treatment Drugs" report to their offering. China's demand for kidney cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ndustry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled. Key Topics Covered: I. Introduction II. Business Environment III. Kidney Cancer Treatment Drugs Industry Assessments IV. Kidney Cancer Treatment Drugs Production And Demand V. Kidney Cancer Treatment Drugs Market Outlook VI. Marketing Strategies VII. Kidney Cancer Treatment Drugs Producer Directory List of Tables List of Charts Companies Mentioned Selected companies Beijing SL Pharmaceutical Co., Ltd Yangtze River Pharmaceutical Group Hangzhou Aoyipollen Pharmaceutical Co., Ltd. Zhuhai Union Pharmaceutical Co., Ltd Shandong Qilu Pharmaceutical Co., Ltd Chengdu Minyi Pharmaceutical Co., Ltd Henan Jiaozuo KL Pharmaceutical Co., Ltd Changzhou Siyao Pharmaceutical Co., Ltd For more information visit http://www.researchandmarkets.com/research/x5zbxd/chinese_markets |
